ANDREOLI, M. T.; PINNOLIS, M.; KIESER, T.; SUN, J.; ANDREOLI, C. M. Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration. Digital Journal of Ophthalmology, Boston, Massachusetts, USA, v. 21, n. 3, p. 29–34, 2015. DOI: 10.5693/djo.01.2015.04.002. Disponível em: https://djo.harvard.edu/index.php/djo/article/view/380. Acesso em: 1 may. 2026.